Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 175

1.

Tnni3k alleles influence ventricular mononuclear diploid cardiomyocyte frequency.

Gan P, Patterson M, Velasquez A, Wang K, Tian D, Windle JJ, Tao G, Judge DP, Makita T, Park TJ, Sucov HM.

PLoS Genet. 2019 Oct 7;15(10):e1008354. doi: 10.1371/journal.pgen.1008354. [Epub ahead of print]

2.

Therapeutic Modulation of the Immune Response in Arrhythmogenic Cardiomyopathy.

Chelko SP, Asimaki A, Lowenthal J, Bueno-Beti C, Bedja D, Scalco A, Amat-Alarcon N, Andersen P, Judge DP, Tung L, Saffitz JE.

Circulation. 2019 Sep 19. doi: 10.1161/CIRCULATIONAHA.119.040676. [Epub ahead of print]

PMID:
31533459
3.

Arrhythmogenic Right Ventricular Cardiomyopathy-Associated Desmosomal Variants Are Rarely De Novo.

van Lint FHM, Murray B, Tichnell C, Zwart R, Amat N, Lekanne Deprez RH, Dittmann S, Stallmeyer B, Calkins H, van der Smagt JJ, van den Wijngaard A, Dooijes D, van der Zwaag PA, Schulze-Bahr E, Judge DP, Jongbloed JDH, van Tintelen JP, James CA.

Circ Genom Precis Med. 2019 Aug;12(8):e002467. doi: 10.1161/CIRCGEN.119.002467. Epub 2019 Aug 6.

PMID:
31386562
4.

Positive family history decreases diagnosis time by over 200.

Brown EE, Fajardo J, Judge DP.

Amyloid. 2019;26(sup1):17. doi: 10.1080/13506129.2019.1582484. No abstract available.

PMID:
31343334
5.

Ankyrin-B dysfunction predisposes to arrhythmogenic cardiomyopathy and is amenable to therapy.

Roberts JD, Murphy NP, Hamilton RM, Lubbers ER, James CA, Kline CF, Gollob MH, Krahn AD, Sturm AC, Musa H, El-Refaey M, Koenig S, Aneq MÅ, Hoorntje ET, Graw SL, Davies RW, Rafiq MA, Koopmann TT, Aafaqi S, Fatah M, Chiasson DA, Taylor MR, Simmons SL, Han M, van Opbergen CJ, Wold LE, Sinagra G, Mittal K, Tichnell C, Murray B, Codima A, Nazer B, Nguyen DT, Marcus FI, Sobriera N, Lodder EM, van den Berg MP, Spears DA, Robinson JF, Ursell PC, Green AK, Skanes AC, Tang AS, Gardner MJ, Hegele RA, van Veen TA, Wilde AA, Healey JS, Janssen PM, Mestroni L, van Tintelen JP, Calkins H, Judge DP, Hund TJ, Scheinman MM, Mohler PJ.

J Clin Invest. 2019 Jul 2;129(8):3171-3184. doi: 10.1172/JCI125538. eCollection 2019 Jul 2.

6.

Definition and treatment of arrhythmogenic cardiomyopathy: an updated expert panel report.

Elliott PM, Anastasakis A, Asimaki A, Basso C, Bauce B, Brooke MA, Calkins H, Corrado D, Duru F, Green KJ, Judge DP, Kelsell D, Lambiase PD, McKenna WJ, Pilichou K, Protonotarios A, Saffitz JE, Syrris P, Tandri H, Te Riele A, Thiene G, Tsatsopoulou A, van Tintelen JP.

Eur J Heart Fail. 2019 Aug;21(8):955-964. doi: 10.1002/ejhf.1534. Epub 2019 Jun 18.

7.

Genetic aetiologies should be considered in paediatric cases of acute heart failure presumed to be myocarditis.

Brown EE, McMilllan KN, Halushka MK, Ravekes WJ, Knight M, Crosson JE, Judge DP, Murphy AM.

Cardiol Young. 2019 Jul;29(7):917-921. doi: 10.1017/S1047951119001124. Epub 2019 Jun 14.

PMID:
31198128
8.

2019 HRS expert consensus statement on evaluation, risk stratification, and management of arrhythmogenic cardiomyopathy.

Towbin JA, McKenna WJ, Abrams DJ, Ackerman MJ, Calkins H, Darrieux FCC, Daubert JP, de Chillou C, DePasquale EC, Desai MY, Estes NAM 3rd, Hua W, Indik JH, Ingles J, James CA, John RM, Judge DP, Keegan R, Krahn AD, Link MS, Marcus FI, McLeod CJ, Mestroni L, Priori SG, Saffitz JE, Sanatani S, Shimizu W, van Tintelen JP, Wilde AAM, Zareba W.

Heart Rhythm. 2019 May 9. pii: S1547-5271(19)30438-2. doi: 10.1016/j.hrthm.2019.05.007. [Epub ahead of print]

PMID:
31078652
9.

Correction: Genetic evaluation of cardiomyopathy: a clinical practice resource of the American College of Medical Genetics and Genomics (ACMG).

Hershberger RE, Givertz MM, Ho CY, Judge DP, Kantor PF, McBride KL, Morales A, Taylor MRG, Vatta M, Ware SM; ACMG Professional Practice and Guidelines Committee.

Genet Med. 2019 Oct;21(10):2406-2409. doi: 10.1038/s41436-019-0521-2.

PMID:
31040388
10.

A new prediction model for ventricular arrhythmias in arrhythmogenic right ventricular cardiomyopathy.

Cadrin-Tourigny J, Bosman LP, Nozza A, Wang W, Tadros R, Bhonsale A, Bourfiss M, Fortier A, Lie ØH, Saguner AM, Svensson A, Andorin A, Tichnell C, Murray B, Zeppenfeld K, van den Berg MP, Asselbergs FW, Wilde AAM, Krahn AD, Talajic M, Rivard L, Chelko S, Zimmerman SL, Kamel IR, Crosson JE, Judge DP, Yap SC, van der Heijden JF, Tandri H, Jongbloed JDH, Guertin MC, van Tintelen JP, Platonov PG, Duru F, Haugaa KH, Khairy P, Hauer RNW, Calkins H, Te Riele ASJM, James CA.

Eur Heart J. 2019 Jun 14;40(23):1850-1858. doi: 10.1093/eurheartj/ehz103.

11.

Transthyretin Stabilization by AG10 in Symptomatic Transthyretin Amyloid Cardiomyopathy.

Judge DP, Heitner SB, Falk RH, Maurer MS, Shah SJ, Witteles RM, Grogan M, Selby VN, Jacoby D, Hanna M, Nativi-Nicolau J, Patel J, Rao S, Sinha U, Turtle CW, Fox JC.

J Am Coll Cardiol. 2019 Jul 23;74(3):285-295. doi: 10.1016/j.jacc.2019.03.012. Epub 2019 Mar 15.

12.

Regional Variation in RBM20 Causes a Highly Penetrant Arrhythmogenic Cardiomyopathy.

Parikh VN, Caleshu C, Reuter C, Lazzeroni LC, Ingles J, Garcia J, McCaleb K, Adesiyun T, Sedaghat-Hamedani F, Kumar S, Graw S, Gigli M, Stolfo D, Dal Ferro M, Ing AY, Nussbaum R, Funke B, Wheeler MT, Hershberger RE, Cook S, Steinmetz LM, Lakdawala NK, Taylor MRG, Mestroni L, Merlo M, Sinagra G, Semsarian C, Meder B, Judge DP, Ashley E.

Circ Heart Fail. 2019 Mar;12(3):e005371. doi: 10.1161/CIRCHEARTFAILURE.118.005371.

PMID:
30871351
13.

Four-Chamber Intracardiac Thrombi Complicating Wild-Type TTR Amyloidosis.

Griffin JM, Judge DP, Zehr KJ, Madrazo J, Rouf R.

Case Rep Cardiol. 2018 Dec 20;2018:1845962. doi: 10.1155/2018/1845962. eCollection 2018.

14.

Cardiac Management of the Patient With Duchenne Muscular Dystrophy.

Buddhe S, Cripe L, Friedland-Little J, Kertesz N, Eghtesady P, Finder J, Hor K, Judge DP, Kinnett K, McNally EM, Raman S, Thompson WR, Wagner KR, Olson AK.

Pediatrics. 2018 Oct;142(Suppl 2):S72-S81. doi: 10.1542/peds.2018-0333I. Review.

15.

Seven factors predict a delayed diagnosis of cardiac amyloidosis.

Bishop E, Brown EE, Fajardo J, Barouch LA, Judge DP, Halushka MK.

Amyloid. 2018 Sep;25(3):174-179. doi: 10.1080/13506129.2018.1498782. Epub 2018 Aug 31.

PMID:
30169971
16.

No major role for rare plectin variants in arrhythmogenic right ventricular cardiomyopathy.

Hoorntje ET, Posafalvi A, Syrris P, van der Velde KJ, Bolling MC, Protonotarios A, Boven LG, Amat-Codina N, Groeneweg JA, Wilde AA, Sobreira N, Calkins H, Hauer RNW, Jonkman MF, McKenna WJ, Elliott PM, Sinke RJ, van den Berg MP, Chelko SP, James CA, van Tintelen JP, Judge DP, Jongbloed JDH.

PLoS One. 2018 Aug 30;13(8):e0203078. doi: 10.1371/journal.pone.0203078. eCollection 2018.

17.

Tafamidis Treatment for Patients with Transthyretin Amyloid Cardiomyopathy.

Maurer MS, Schwartz JH, Gundapaneni B, Elliott PM, Merlini G, Waddington-Cruz M, Kristen AV, Grogan M, Witteles R, Damy T, Drachman BM, Shah SJ, Hanna M, Judge DP, Barsdorf AI, Huber P, Patterson TA, Riley S, Schumacher J, Stewart M, Sultan MB, Rapezzi C; ATTR-ACT Study Investigators.

N Engl J Med. 2018 Sep 13;379(11):1007-1016. doi: 10.1056/NEJMoa1805689. Epub 2018 Aug 27.

18.

Managing Secondary Genomic Findings Associated With Arrhythmogenic Right Ventricular Cardiomyopathy: Case Studies and Proposal for Clinical Surveillance.

Haggerty CM, Murray B, Tichnell C, Judge DP, Tandri H, Schwartz M, Sturm AC, Matsumura ME, Murray MF, Calkins H, Fornwalt BK, James CA.

Circ Genom Precis Med. 2018 Jul;11(7):e002237. doi: 10.1161/CIRCGEN.118.002237. No abstract available.

PMID:
29997227
19.

Bringing Autopsies Into the Molecular Genetic Era.

Judge DP, Brown EE.

Circulation. 2018 Jun 19;137(25):2727-2729. doi: 10.1161/CIRCULATIONAHA.118.033235. No abstract available.

PMID:
29915099
20.

Genetic evaluation of cardiomyopathy: a clinical practice resource of the American College of Medical Genetics and Genomics (ACMG).

Hershberger RE, Givertz MM, Ho CY, Judge DP, Kantor PF, McBride KL, Morales A, Taylor MRG, Vatta M, Ware SM; ACMG Professional Practice and Guidelines Committee.

Genet Med. 2018 Sep;20(9):899-909. doi: 10.1038/s41436-018-0039-z. Epub 2018 Jun 14. Erratum in: Genet Med. 2019 Oct;21(10):2406-2409.

PMID:
29904160
21.

Identification of sarcomeric variants in probands with a clinical diagnosis of arrhythmogenic right ventricular cardiomyopathy (ARVC).

Murray B, Hoorntje ET, Te Riele ASJM, Tichnell C, van der Heijden JF, Tandri H, van den Berg MP, Jongbloed JDH, Wilde AAM, Hauer RNW, Calkins H, Judge DP, James CA, van Tintelen JP, Dooijes D.

J Cardiovasc Electrophysiol. 2018 Jul;29(7):1004-1009. doi: 10.1111/jce.13621. Epub 2018 May 21.

22.

Protein molecular modeling techniques investigating novel TAB2 variant R347X causing cardiomyopathy and congenital heart defects in multigenerational family.

Caulfield TR, Richter JE Jr, Brown EE, Mohammad AN, Judge DP, Atwal PS.

Mol Genet Genomic Med. 2018 Apr 26. doi: 10.1002/mgg3.401. [Epub ahead of print]

23.

Genetic Evaluation of Cardiomyopathy-A Heart Failure Society of America Practice Guideline.

Hershberger RE, Givertz MM, Ho CY, Judge DP, Kantor PF, McBride KL, Morales A, Taylor MRG, Vatta M, Ware SM.

J Card Fail. 2018 May;24(5):281-302. doi: 10.1016/j.cardfail.2018.03.004. Epub 2018 Mar 19. Review.

PMID:
29567486
24.

Performance of the 2015 International Task Force Consensus Statement Risk Stratification Algorithm for Implantable Cardioverter-Defibrillator Placement in Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy.

Orgeron GM, Te Riele A, Tichnell C, Wang W, Murray B, Bhonsale A, Judge DP, Kamel IR, Zimmerman SL, Tandri H, Calkins H, James CA.

Circ Arrhythm Electrophysiol. 2018 Feb;11(2):e005593. doi: 10.1161/CIRCEP.117.005593. Epub 2018 Feb 16.

PMID:
29453325
25.

Inheritance Impacts Mitral Valve Insufficiency.

Judge DP, Norris RA.

Circ Cardiovasc Genet. 2017 Oct;10(5). pii: e001920. doi: 10.1161/CIRCGENETICS.117.001920. No abstract available.

PMID:
28993408
26.

Designing a course model for distance-based online bioinformatics training in Africa: The H3ABioNet experience.

Gurwitz KT, Aron S, Panji S, Maslamoney S, Fernandes PL, Judge DP, Ghouila A, Domelevo Entfellner JB, Guerfali FZ, Saunders C, Mansour Alzohairy A, Salifu SP, Ahmed R, Cloete R, Kayondo J, Ssemwanga D, Mulder N; H3ABioNet Consortium's Education Training and Working Group as members of the H3Africa Consortium.

PLoS Comput Biol. 2017 Oct 5;13(10):e1005715. doi: 10.1371/journal.pcbi.1005715. eCollection 2017 Oct.

27.

Arrhythmogenic cardiomyopathy: pathology, genetics, and concepts in pathogenesis.

Hoorntje ET, Te Rijdt WP, James CA, Pilichou K, Basso C, Judge DP, Bezzina CR, van Tintelen JP.

Cardiovasc Res. 2017 Oct 1;113(12):1521-1531. doi: 10.1093/cvr/cvx150. Review.

PMID:
28957532
28.

Arrhythmogenic Cardiomyopathy.

Corrado D, Basso C, Judge DP.

Circ Res. 2017 Sep 15;121(7):784-802. doi: 10.1161/CIRCRESAHA.117.309345. Review.

PMID:
28912183
29.

Heart Failure Is Common and Under-Recognized in Patients With Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia.

Gilotra NA, Bhonsale A, James CA, Te Riele ASJ, Murray B, Tichnell C, Sawant A, Ong CS, Judge DP, Russell SD, Calkins H, Tedford RJ.

Circ Heart Fail. 2017 Sep;10(9). pii: e003819. doi: 10.1161/CIRCHEARTFAILURE.116.003819.

PMID:
28874384
30.

Management of Cardiac Involvement Associated With Neuromuscular Diseases: A Scientific Statement From the American Heart Association.

Feingold B, Mahle WT, Auerbach S, Clemens P, Domenighetti AA, Jefferies JL, Judge DP, Lal AK, Markham LW, Parks WJ, Tsuda T, Wang PJ, Yoo SJ; American Heart Association Pediatric Heart Failure Committee of the Council on Cardiovascular Disease in the Young; Council on Clinical Cardiology; Council on Cardiovascular Radiology and Intervention; Council on Functional Genomics and Translational Biology; and Stroke Council.

Circulation. 2017 Sep 26;136(13):e200-e231. doi: 10.1161/CIR.0000000000000526. Epub 2017 Aug 24.

PMID:
28838934
31.

Role of Genetic Testing in Inherited Cardiovascular Disease: A Review.

Cirino AL, Harris S, Lakdawala NK, Michels M, Olivotto I, Day SM, Abrams DJ, Charron P, Caleshu C, Semsarian C, Ingles J, Rakowski H, Judge DP, Ho CY.

JAMA Cardiol. 2017 Oct 1;2(10):1153-1160. doi: 10.1001/jamacardio.2017.2352. Review.

PMID:
28793145
32.

The Role of Genetics in Peripartum Cardiomyopathy.

Lee YZJ, Judge DP.

J Cardiovasc Transl Res. 2017 Dec;10(5-6):437-445. doi: 10.1007/s12265-017-9764-y. Epub 2017 Aug 3. Review.

PMID:
28776299
33.

Nonmyocyte ERK1/2 signaling contributes to load-induced cardiomyopathy in Marfan mice.

Rouf R, MacFarlane EG, Takimoto E, Chaudhary R, Nagpal V, Rainer PP, Bindman JG, Gerber EE, Bedja D, Schiefer C, Miller KL, Zhu G, Myers L, Amat-Alarcon N, Lee DI, Koitabashi N, Judge DP, Kass DA, Dietz HC.

JCI Insight. 2017 Aug 3;2(15). pii: 91588. doi: 10.1172/jci.insight.91588. eCollection 2017 Aug 3.

34.

Long-term safety and efficacy of tafamidis for the treatment of hereditary transthyretin amyloid polyneuropathy: results up to 6 years.

Barroso FA, Judge DP, Ebede B, Li H, Stewart M, Amass L, Sultan MB.

Amyloid. 2017 Sep;24(3):194-204. doi: 10.1080/13506129.2017.1357545. Epub 2017 Jul 31.

PMID:
28758793
35.

Giant Ring Mitochondria in a Patient With Heart Failure and Cerebral White Matter Disease Resulting From an MT-TL1 Mitochondrial Gene Mutation.

Houston BA, Judge DP, Brown E, Halushka M, Barouch LA.

J Card Fail. 2017 Aug;23(8):652-655. doi: 10.1016/j.cardfail.2017.06.001. Epub 2017 Jun 15.

PMID:
28624653
36.

Cutaneous nerve biomarkers in transthyretin familial amyloid polyneuropathy.

Ebenezer GJ, Liu Y, Judge DP, Cunningham K, Truelove S, Carter ND, Sebastian B, Byrnes K, Polydefkis M.

Ann Neurol. 2017 Jul;82(1):44-56. doi: 10.1002/ana.24972. Epub 2017 Jun 20.

PMID:
28598015
37.

Implantable Cardioverter-Defibrillator Therapy in Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy: Predictors of Appropriate Therapy, Outcomes, and Complications.

Orgeron GM, James CA, Te Riele A, Tichnell C, Murray B, Bhonsale A, Kamel IR, Zimmerman SL, Judge DP, Crosson J, Tandri H, Calkins H.

J Am Heart Assoc. 2017 Jun 6;6(6). pii: e006242. doi: 10.1161/JAHA.117.006242.

38.

Comparison of Features of Fatal Versus Nonfatal Cardiac Arrest in Patients With Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy.

Gupta R, Tichnell C, Murray B, Rizzo S, Te Riele A, Tandri H, Judge DP, Thiene G, Basso C, Calkins H, James CA.

Am J Cardiol. 2017 Jul 1;120(1):111-117. doi: 10.1016/j.amjcard.2017.03.251. Epub 2017 Apr 13.

PMID:
28506445
39.

Genetic testing improves identification of transthyretin amyloid (ATTR) subtype in cardiac amyloidosis.

Brown EE, Lee YZJ, Halushka MK, Steenbergen C, Johnson NM, Almansa J, Tedford RJ, Cingolani O, Russell SD, Sharma K, Judge DP.

Amyloid. 2017 Jun;24(2):92-95. doi: 10.1080/13506129.2017.1324418. Epub 2017 May 11.

PMID:
28494620
40.

Cardiac phenotype and long-term prognosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia patients with late presentation.

Bhonsale A, Te Riele ASJM, Sawant AC, Groeneweg JA, James CA, Murray B, Tichnell C, Mast TP, van der Pols MJ, Cramer MJM, Dooijes D, van der Heijden JF, Tandri H, van Tintelen JP, Judge DP, Hauer RNW, Calkins H.

Heart Rhythm. 2017 Jun;14(6):883-891. doi: 10.1016/j.hrthm.2017.02.013. Epub 2017 Feb 12.

41.

Angiotensin II antagonism is associated with reduced risk for gastrointestinal bleeding caused by arteriovenous malformations in patients with left ventricular assist devices.

Houston BA, Schneider AL, Vaishnav J, Cromwell DM, Miller PE, Faridi KF, Shah A, Sciortino C, Whitman G, Tedford RJ, Stevens GR, Judge DP, Russell SD, Rouf R.

J Heart Lung Transplant. 2017 Apr;36(4):380-385. doi: 10.1016/j.healun.2016.12.016. Epub 2016 Dec 30.

PMID:
28169115
42.

Evaluation of Structural Progression in Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy.

Mast TP, James CA, Calkins H, Teske AJ, Tichnell C, Murray B, Loh P, Russell SD, Velthuis BK, Judge DP, Dooijes D, Tedford RJ, van der Heijden JF, Tandri H, Hauer RN, Abraham TP, Doevendans PA, Te Riele AS, Cramer MJ.

JAMA Cardiol. 2017 Mar 1;2(3):293-302. doi: 10.1001/jamacardio.2016.5034.

PMID:
28097316
43.

Neonatal Transplantation Confers Maturation of PSC-Derived Cardiomyocytes Conducive to Modeling Cardiomyopathy.

Cho GS, Lee DI, Tampakakis E, Murphy S, Andersen P, Uosaki H, Chelko S, Chakir K, Hong I, Seo K, Chen HV, Chen X, Basso C, Houser SR, Tomaselli GF, O'Rourke B, Judge DP, Kass DA, Kwon C.

Cell Rep. 2017 Jan 10;18(2):571-582. doi: 10.1016/j.celrep.2016.12.040.

44.

Multilevel analyses of SCN5A mutations in arrhythmogenic right ventricular dysplasia/cardiomyopathy suggest non-canonical mechanisms for disease pathogenesis.

Te Riele AS, Agullo-Pascual E, James CA, Leo-Macias A, Cerrone M, Zhang M, Lin X, Lin B, Sobreira NL, Amat-Alarcon N, Marsman RF, Murray B, Tichnell C, van der Heijden JF, Dooijes D, van Veen TA, Tandri H, Fowler SJ, Hauer RN, Tomaselli G, van den Berg MP, Taylor MR, Brun F, Sinagra G, Wilde AA, Mestroni L, Bezzina CR, Calkins H, Peter van Tintelen J, Bu L, Delmar M, Judge DP.

Cardiovasc Res. 2017 Jan;113(1):102-111. doi: 10.1093/cvr/cvw234. Erratum in: Cardiovasc Res. 2017 May 1;113(6):691.

45.

Baseline Characteristics Predict the Presence of Amyloid on Endomyocardial Biopsy.

Ton VK, Bhonsale A, Gilotra NA, Halushka MK, Steenbergen C, Almansa J, Brown E, Tedford RJ, Wittstein I, Sharma K, Russell SD, Judge DP.

J Card Fail. 2017 Apr;23(4):340-344. doi: 10.1016/j.cardfail.2016.12.006. Epub 2016 Dec 20.

PMID:
28011000
46.

GLA-Ring Opportunities and Challenges for Fabry Disease.

Judge DP, Okwuosa IS, Hagège AA.

J Am Coll Cardiol. 2016 Dec 13;68(23):2564-2566. doi: 10.1016/j.jacc.2016.09.952. No abstract available.

47.

Untangling Wild-Type Transthyretin Amyloidosis.

Judge DP, Lee YZ, Sharma K.

J Am Coll Cardiol. 2016 Sep 6;68(10):1021-3. doi: 10.1016/j.jacc.2016.06.032. No abstract available.

48.

Genotype and Phenotype of Transthyretin Cardiac Amyloidosis: THAOS (Transthyretin Amyloid Outcome Survey).

Maurer MS, Hanna M, Grogan M, Dispenzieri A, Witteles R, Drachman B, Judge DP, Lenihan DJ, Gottlieb SS, Shah SJ, Steidley DE, Ventura H, Murali S, Silver MA, Jacoby D, Fedson S, Hummel SL, Kristen AV, Damy T, Planté-Bordeneuve V, Coelho T, Mundayat R, Suhr OB, Waddington Cruz M, Rapezzi C; THAOS Investigators.

J Am Coll Cardiol. 2016 Jul 12;68(2):161-72. doi: 10.1016/j.jacc.2016.03.596.

49.

Central role for GSK3β in the pathogenesis of arrhythmogenic cardiomyopathy.

Chelko SP, Asimaki A, Andersen P, Bedja D, Amat-Alarcon N, DeMazumder D, Jasti R, MacRae CA, Leber R, Kleber AG, Saffitz JE, Judge DP.

JCI Insight. 2016 Apr 21;1(5). pii: 85923. doi: 10.1172/jci.insight.85923.

50.

Right ventricular afterload sensitivity dramatically increases after left ventricular assist device implantation: A multi-center hemodynamic analysis.

Houston BA, Kalathiya RJ, Hsu S, Loungani R, Davis ME, Coffin ST, Haglund N, Maltais S, Keebler ME, Leary PJ, Judge DP, Stevens GR, Rickard J, Sciortino CM, Whitman GJ, Shah AS, Russell SD, Tedford RJ.

J Heart Lung Transplant. 2016 Jul;35(7):868-76. doi: 10.1016/j.healun.2016.01.1225. Epub 2016 Feb 9.

Supplemental Content

Loading ...
Support Center